Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Interest & Investment Income (2022 - 2025)

Maravai Lifesciences Holdings (MRVI) has 4 years of Interest & Investment Income data on record, last reported at $2.4 million in Q4 2025.

  • For Q4 2025, Interest & Investment Income fell 60.5% year-over-year to $2.4 million; the TTM value through Dec 2025 reached $11.4 million, down 58.27%, while the annual FY2025 figure was $11.4 million, 58.27% down from the prior year.
  • Interest & Investment Income reached $2.4 million in Q4 2025 per MRVI's latest filing, down from $2.8 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $7.5 million in Q4 2023 and bottomed at $2.3 million in Q4 2022.
  • Average Interest & Investment Income over 4 years is $5.3 million, with a median of $6.0 million recorded in 2023.
  • Peak YoY movement for Interest & Investment Income: surged 219.03% in 2023, then tumbled 60.5% in 2025.
  • A 4-year view of Interest & Investment Income shows it stood at $2.3 million in 2022, then soared by 219.03% to $7.5 million in 2023, then fell by 19.08% to $6.0 million in 2024, then tumbled by 60.5% to $2.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Interest & Investment Income were $2.4 million in Q4 2025, $2.8 million in Q3 2025, and $3.0 million in Q2 2025.